Skip to main content
. 2017 Sep 26;153(1):1–9. doi: 10.1111/imm.12829

Table 1.

Viral vaccine vectors discussed in this review and their characteristics

Vector Type of virus Cargo capacity (kb) Predominant immune response Clinical development stage
Cytomegalovirus DNA >6 CD4+, CD8+ and antibodies Phase I
Novel adenoviruses DNA 7 CD8+ and antibodies Phase II
Vesicular stomatitis virus ‐ssRNA 6 Antibodies and some CD4+, CD8+ Phase III
Measles virus ‐ssRNA >6 CD4+ and antibodies Phase I